ReviR Therapeutics (ReviR), a biotechnology company developing small molecule therapies targeting RNA, today announced an upcoming presentation at the 5th Annual RNA Targeted Drug Discovery conference taking place December 13-15, 2022 in Boston, MA.
December 8, 2022
· 1 min read